Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- CNTX
- Price
- 1.79
- Stock movement up
- +0.15 (9.15%)
- Company name
- Context Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 164.46M
- Ent value
- 93.58M
- Price/Sales
- -
- Price/Book
- 2.25
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -6.06%
- 1 year return (CAGR)
- 83.74%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CNTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 2.25 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 91.88M |
| EPS (TTM) | -0.28 |
| FCF per share (TTM) | -0.24 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -8.13K |
| Operating income (TTM) | -30.21M |
| Net income (TTM) | -26.44M |
| EPS (TTM) | -0.28 |
| EPS (1y forward) | -0.41 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 76.94M |
| Net receivables | 0.00 |
| Total current assets | 78.86M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 172.34K |
| Total assets | 79.23M |
| Accounts payable | 2.72M |
| Short/Current long term debt | 140.20K |
| Total current liabilities | 6.04M |
| Total liabilities | 6.06M |
| Shareholder's equity | 73.17M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -22.35M |
| Capital expenditures (TTM) | 33.95K |
| Free cash flow (TTM) | -22.38M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -36.13% |
| Return on Assets | -33.37% |
| Return on Invested Capital | -36.08% |
| Cash Return on Invested Capital | -30.54% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.65 |
| Daily high | 1.79 |
| Daily low | 1.63 |
| Daily Volume | 1.84M |
| All-time high | 7.45 |
| 1y analyst estimate | 5.57 |
| Beta | 1.94 |
| EPS (TTM) | -0.28 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CNTX | S&P500 | |
| Current price drop from All-time high | -75.97% | -0.89% |
| Highest price drop | -92.60% | -19.00% |
| Date of highest drop | 1 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -85.62% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
164.46M
Marketcap category
Small-cap
Description
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Employees
12
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page